When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. FDA approves new pain medication as an alternative to opioids ...

    www.aol.com/fda-approves-pain-medication...

    Updated January 31, 2025 at 10:03 ... Vertex Pharmaceuticals claimed in a press release that the medication can be used for many types of moderate-to-severe acute pain and has shown no ...

  3. Pharma Stock Roundup: FDA Updates for LLY, AZN, MRK ... - AOL

    www.aol.com/news/pharma-stock-roundup-fda...

    FDA approves Lilly's (LLY) selpercatinib for RET-altered lung and thyroid cancers and AstraZeneca (AZN)/Merck's (MRK) Lynparza for new ovarian cancer use.

  4. Purdue Pharma, Sackler families boost contribution in opioid ...

    www.aol.com/news/purdue-pharma-sackler-families...

    The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...

  5. Pharma Stock Roundup: FDA Panel's Nod to PFE/BNTX ... - AOL

    www.aol.com/news/pharma-stock-roundup-fda-panels...

    An FDA panel recommends granting approval for emergency use of Pfizer's (PFE) COVID-19 vaccine. Glaxo (GSK)/Sanofi (SNY) COVID-19 vaccine plan delays.

  6. Large Cap Pharma, Biotech Stocks Down on Regulatory Updates - AOL

    www.aol.com/news/large-cap-pharma-biotech-stocks...

    Pharma giants like Pfizer (PFE), Merck (MRK) and Eli Lilly (LLY), along with biotech bigwig Regeneron (REGN), are down on regulatory updates.

  7. Pharma Stock Roundup: FDA Updates on MRK, AZN's Cancer ... - AOL

    www.aol.com/news/pharma-stock-roundup-fda...

    For premium support please call: 800-290-4726 more ways to reach us

  8. List of largest pharmaceutical mergers and acquisitions

    en.wikipedia.org/wiki/List_of_largest...

    Valeant Pharmaceuticals: Allergan, Inc: 45 58 Valeant Pharmaceuticals and activist investor Bill Ackman offered to buy Botox maker Allergan, proposing a cash-and-stock deal worth about $152.89. [31] 20 2014 Monsanto Company Inc. Syngenta AG: 40 51 Monsanto weighed $40 billion unsolicited bid for Swiss rival, Syngenta aiming to avoid US ...

  9. Pharma Stock Roundup: FDA Approves Expanded Use of MRK ... - AOL

    www.aol.com/news/pharma-stock-roundup-fda...

    For premium support please call: 800-290-4726 more ways to reach us